Novel pharmacology of cannabidivarin, tetrahydrocannabivarin, cannabigerol, and cannabichromene in vitro and in vivo

被引：0
|
作者：
Laprairie, Robert [1 ]
Mohamed, Kawthar [1 ]
Kim, David [1 ]
Zagzoog, Ayat [1 ]
机构：
[1] Univ Saskatchewan, Saskatoon, SK, Canada
来源：
BRITISH JOURNAL OF PHARMACOLOGY | 2020年 / 177卷 / 11期
关键词：
THC;
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
P228
引用
收藏
页码：2626 / 2627
页数：2
相关论文
共 50 条
  • [21] Lumbriculus variegatus: A novel organism for in vivo pharmacology education
    Seeley, Aidan
    Bellamy, Caitlin
    Davies, Nia A.
    Wallace, Melisa J.
    PHARMACOLOGY RESEARCH & PERSPECTIVES, 2021, 9 (05):
  • [22] In-vitro and in-vivo pharmacology of a novel TRPV1 receptor antagonist: JNJ38748021
    Bhattacharya, Anindya
    Hawryluk, Natalie A.
    Merit, Jeffrey E.
    Nasser, Nadia
    Ao, Hong
    Wang, Qi
    Tham, Chui-Se
    Maher, Michael P.
    Kansagara, Mena
    Scott, Brian P.
    Hack, Michael D.
    Breitenbucher, James G.
    Chaplan, Sandra R.
    Wickenden, Alan D.
    FASEB JOURNAL, 2008, 22
  • [23] Preclinical pharmacology of RA15127343: In vitro and in vivo activity of a novel ultralong-acting basal insulin
    Werner, Ulrich
    Bielohuby, Maximilian
    Korn, Marcus
    Riedel, Jens
    Will, Martin
    Mendez, Maria
    DIABETES OBESITY & METABOLISM, 2022, 24 (12): : 2411 - 2419
  • [24] In vitro pharmacology of the novel enterokinetic R093877.
    Briejer, MR
    Meulemans, AL
    Bosmans, JP
    VanDaele, P
    Schuurkes, JAJ
    GASTROENTEROLOGY, 1997, 112 (04) : A705 - A705
  • [25] Synthesis, characterization and in vitro pharmacology of novel pregabalin derivatives
    Horvat, Stefica
    Hamersak, Zdenko
    Stipetic, Irena
    Jolas, Thierry
    EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2010, 45 (04) : 1447 - 1452
  • [26] In vitro activity and in vivo pharmacology of two novel nucleoside transport inhibitors, NU3108 and NU3121.
    Smith, PG
    Thomas, HD
    Barlow, HC
    Griffin, RJ
    Golding, BT
    Calvert, AH
    Newell, DR
    Curtin, NJ
    CLINICAL CANCER RESEARCH, 2000, 6 : 4555S - 4555S
  • [27] Lumbriculus variegatus: A novel in vivo model organism for pharmacology research
    Seeley, Aidan
    Wallace, Lisa
    Sobhanpanah, Kian
    Emm, Andrew
    Davies, Mairead
    BRITISH JOURNAL OF PHARMACOLOGY, 2020, 177 (11) : 2550 - 2550
  • [28] In vitro and in vivo pharmacology of S 16474, a novel dual tachykinin NK1 and NK2 receptor antagonist
    Robineau, P
    Lonchampt, M
    Kucharczyk, N
    Krause, JE
    Regoli, D
    Fauchere, JL
    Prost, JF
    Canet, E
    EUROPEAN JOURNAL OF PHARMACOLOGY, 1995, 294 (2-3) : 677 - 684
  • [29] 7-Aryl-7-deazapurine 3′-deoxyribonucleoside derivative as a novel lead for Chagas' disease therapy: in vitro and in vivo pharmacology
    Cardoso-Santos, Camila
    de Almeida Fiuza, Ludmila Ferreira
    da Silva, Cristiane Franca
    Mazzeti, Ana Lia
    Girao, Roberson Donola
    de Oliveira, Gabriel Melo
    Jaen Batista, Denise da Gama
    Moreira, Otacilio Cruz
    da Silva Gomes, Natalia Lins
    Maes, Louis
    Caljon, Guy
    Hulpia, Fabian
    Calenbergh, Serge, V
    Correia Soeiro, Maria de Nazare
    JAC-ANTIMICROBIAL RESISTANCE, 2021, 3 (04):
  • [30] STUDIES ON BIOCHEMICAL PHARMACOLOGY OF 5-IODO-2'-DEOXYCYTIDINE IN VITRO AND IN VIVO
    CRAMER, JW
    PRUSOFF, WH
    ESSEN, CFV
    SARTORELLI, AC
    WELCH, AD
    CHANG, PK
    DELAMORE, IW
    BIOCHEMICAL PHARMACOLOGY, 1962, 11 (AUG) : 761 - +
12345